Market Access Consolidating data strategy for global success: Insights fro... At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
Digital Consolidating Digital Health: Insights from Frontiers Health... Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights.
Digital Building a Molecular Time Machine: Insights from Frontiers H... pharmaphorum grabbed a moment with Alkahest Head of Data Science Benoit LeHallier after his talk at Frontiers Health.
Digital Humans in Extremes: Insights from Frontiers Health 2025 pharmaphorum chatted with Jack Kreindler (WellFounded) after his onstage session at Frontiers Health 2025.
Digital Humanity as a Feature, Not a Bug: Insights from Frontiers He... YourCoach Health’s Eugene and Marina Borukhovich spoke with pharmaphorum after their Frontiers Health session.
Digital Transforming Pharma: Insights from Frontiers Health 2025 pharmaphorum caught up with Emre Ozcan (Merck Group) after his onstage session at Frontiers Health.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.